Symbiox Investment & Trading Company Ltd (SYMBIOX) Announcements - Latest Exchange Filings with AI Summaries
Latest corporate announcements filed by Symbiox Investment & Trading Company Ltd on NSE and BSE, with an AI summary of each filing.
Non - Applicability of Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI (LODR) Regualtions, 2015.
Others (Uncategorized) · 02 Nov 2026, 10:33 pm
Symbiox Investment Confirms Nil Fund Raising and Non-Applicability of Regulation 32 Symbiox Investment & Trading Co. Ltd. confirmed to exchanges that it did not raise any capital via Public Issue, Rights Issue, Preferential Issue, or Qualified Institutional Placement (QIP) during the quarter ended 30th Sep'26. Consequently, the requirement to submit a Statement of Deviation or Variation in fund utilization under Regulation 32 of SEBI (LODR) Regulations, 2015 remains non-applicable to the company for the period.
The Exchange has sought clarification from Symbiox Investment & Trading Company Ltd on October 05, 2026 with reference to significant movement in price, in order to ensure that investors ....
Others (Uncategorized) · 05 Oct 2026, 10:48 pm
Declaration of Voting Result under Regulation 44(3) of SEBI (LODR) Regulations, 2015 of 47th Annual General Meeting of the Company held on 28th September, 2026.
Annual General Meeting · 29 Sept 2026, 7:43 pm
Outcome of AGM held on 28th September, 2026.
Annual General Meeting · 28 Sept 2026, 7:57 pm
With reference to above mentioned subject, please find herewith attached copy of Annual Report of the Company for the year ended 31st March, 2026
Others (Uncategorized) · 04 Sept 2026, 8:31 pm
Intimation Regulation 36(1)(b) of LODR.
Others (Uncategorized) · 04 Sept 2026, 5:50 pm
Intimation of AGM Notice
Annual General Meeting · 04 Sept 2026, 5:41 pm
We wish to inform you that the meeting of the Board of Directors of M/s. Symbiox Investment & Trading Company Limited was held on Wednesday, 26th August, 2026 at 02:00 P.M. at the Registered ....
Outcome · 26 Aug 2026, 8:14 pm
Symbiox Investment & Trading Board Sets AGM and E-Voting Dates Symbiox Investment & Trading will hold its 47th Annual General Meeting (AGM) via video conference on 28th Sep'26 at 01:30 PM. The board, in its meeting on 26th Aug'26, approved the FY26 Director's Report. The register of members will be closed from 22nd Sep'26 to 28th Sep'26. The cut-off date for shareholder eligibility for e-voting is 21st Sep'26. The remote e-voting period will run from 25th Sep'26 to 27th Sep'26. Akhil Agarwal has been appointed as the scrutinizer.
Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 26/08/2026 ,inter alia, to consider and approve the Director ....
Intimation · 22 Aug 2026, 7:12 pm
Outcome of Board Meeting held on 12th August, 2026 for the quarter ended on 30th June, 2026.
Outcome · 12 Aug 2026, 9:36 pm
Symbiox Q1FY27: PAT Grows 15.5% YoY, But Declines Sharply QoQ Symbiox Investment reported Q1FY27 results, posting a Profit After Tax (PAT) of ₹7.73 lakh, a 15.5% YoY increase from ₹6.69 lakh but a significant 525% QoQ surge from ₹1.22 lakh. Revenue from operations declined 44.3% YoY to ₹25.53 lakh and 69.1% QoQ. Total expenses decreased 59.2% YoY and 81.4% QoQ to ₹15.08 lakh. The board approved the unaudited financial results for the quarter ended 30th Jun'26 and adopted the auditor's limited review report, which contained no qualifications.
Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2026 ,inter alia, to consider and approve Pursuant ....
Intimation · 12 Aug 2026, 5:30 am
Symbiox Investment & Trading Co. Board Meeting Set for Aug'26 to Approve Q1 Results Symbiox Investment & Trading Co. has scheduled a Board of Directors meeting for 12th Aug'26. The board will consider and approve the unaudited financial results and the Limited Review Report for the quarter ended 30th Jun'26.
Non - Applicability of Statement of Deviation or Variation under Regulation 32 of SEBI (LODR) Regulations, 2015.
Others (Uncategorized) · 04 Aug 2026, 10:16 pm
Symbiox Investment Confirms No Deviation in Fund Utilization for Q1 FY27 Symbiox Investment & Trading Co. Ltd. confirmed to exchanges on 4th Aug'26 that the statement of deviation or variation in fund utilization is not applicable for the quarter ended 30th Jun'26. The company stated it has not raised any funds through Public Issue, Rights Issue, Preferential Issue, QIP, or other means during the period. This declaration was made in compliance with Regulation 32 of the SEBI (LODR) Regulations, 2015.
pfa
Financial Result · 29 May 2026, 5:08 pm
Symbiox Investment Reports FY26 Results and Approves Auditor Re-appointments Symbiox Investment reported FY26 results with audited net profit at ₹15.23 lakh, down from ₹19.19 lakh YoY. Revenue from operations for FY26 was ₹160.29 lakh versus ₹276.36 lakh YoY. For Q4 FY26, net profit was ₹1.22 lakh on revenue of ₹82.73 lakh. The Board, in its meeting on 23rd May'26, also approved the audited financial results for the quarter and year ended 31st Mar'26. Additionally, it re-appointed the Secretarial Auditor and Internal Auditor for FY 2026-27.
pfa
Change in Management · 23 May 2026, 8:51 pm
Symbiox Board Approves FY26 Results and Re-appoints Auditors The Board of Directors of Symbiox Investment & Trading, in a meeting on 23rd May'26, approved the audited financial results for the quarter and year ended 31st Mar'26. The board also approved the re-appointment of Mr. Akhil Agarwal as Secretarial Auditor and Mrs. Shikha Singhal Chartered Accountants as Internal Auditor for FY 2026-27. Both appointments were recommended by the Audit Committee as the current terms of the auditors had expired. The meeting commenced at 1:30 P.M. and concluded at 02:55 P.M.
Pursuant to the provisions of Reg 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 ('SEBI Regulations'), the Board of ....
Outcome · 23 May 2026, 8:42 pm
Symbiox Investment Posts Q4FY26 PAT of ₹1.22 Lakh, FY26 PAT Down 20.6% YoY Symbiox Investment & Trading reported Q4FY26 results on 23 May'26, posting a Profit After Tax (PAT) of ₹1.22 lakh versus a loss of ₹29.94 lakh YoY. Revenue from operations for the quarter stood at ₹82.73 lakh, a 33.5% YoY decline. For the full year FY26, PAT fell 20.6% YoY to ₹15.23 lakh from ₹19.19 lakh in FY25, while annual revenue dropped 42.0% YoY to ₹160.29 lakh. The board also approved the re-appointment of the Secretarial and Internal Auditors for FY27.
Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 23/05/2026 ,inter alia, to consider and approve Pursuant ....
Intimation · 23 May 2026, 5:30 am
Symbiox Board Meeting on 23rd May'26 to Approve Q4 FY26 Results Symbiox Investment & Trading Co. has scheduled a Board of Directors meeting on 23rd May'26. The primary agenda is to consider and approve the audited financial results for the quarter and year ended 31st Mar'26. The board will also review the Limited Review Report for the same period. Additionally, the appointment of the Secretarial Auditor and Internal Auditor for FY 2026-27 will be considered.
Non - Applicability of Regulation 32of SEBI ( Listing Obligations and Disclosure Requirements ) Regulations, 2015.
Others (Uncategorized) · 27 Apr 2026, 11:19 pm
Symbiox Investment & Trading Confirms No Fund Raising in Q4 FY26 Symbiox Investment & Trading Co. Ltd. confirmed on 27th Apr'26 that it has not raised any funds through a Public Issue, Rights Issue, Preferential Issue, or QIP during the quarter ended 31st Mar'26. Consequently, the company stated that the requirement to submit a statement of deviation or variation in the utilisation of funds under Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable for the period. This indicates no new capital infusion from the market during Q4.
Symbiox Investment & Trading Co Ltd is not identified as Large Corporate as per the framework provided in the aforesaid circular.
Others (Uncategorized) · 27 Apr 2026, 7:22 pm
Symbiox Investment Not Classified as a Large Corporate by SEBI Symbiox Investment & Trading Co Ltd has disclosed that as of 31st Mar'26, the company does not meet the criteria to be classified as a "Large Corporate" under the SEBI framework. This declaration, made on 27th Apr'26, pertains to SEBI Circular SEBI/HO/DDHS/P/CIR/2021/613, which mandates specific fundraising and disclosure compliances for companies identified as Large Corporates. Consequently, Symbiox is not subject to these particular regulations for the period.
Non - Applicability of Statement of Deviation or Variation in Utilisation of Funds under Regulation 32 of SEBI ( LODR ) Regulations, 2015.
Others (Uncategorized) · 11 Feb 2026, 8:43 pm
Symbiox Investment Confirms No Fund Raising Activity in Q3 FY26 Symbiox Investment & Trading Co. Ltd. (BSE: 539278) confirmed on 11th Feb'26 that it has not raised any funds through public issue, rights issue, preferential issue, or QIP during the quarter ended 31st Dec'25. Consequently, the statement of deviation or variation in fund utilization under Regulation 32 of SEBI (LODR) Regulations, 2015 is not applicable for the period. This indicates no new equity dilution or capital infusion from these specific routes during Q3 FY26.
Revision of Outcome of Board Meeting held on 7th February,2026.
Outcome · 07 Feb 2026, 9:42 pm
Symbiox Investment Q3 FY26 Results Show Sharp Decline in Profit and Revenue Symbiox Investment & Trading reported a significant decline in its Q3 FY26 results. Net profit for the quarter ended 31 Dec'25 stood at ₹1.23 lakhs, down 92.2% YoY from ₹15.85 lakhs and 80.0% QoQ from ₹6.09 lakhs. Revenue from operations fell 81.1% YoY to ₹8.60 lakhs. The board approved the unaudited financial results on 7 Feb'26. Basic EPS for the quarter was ₹0.004, a sharp decrease from ₹0.051 in Q3 FY25. The results received a clean limited review report from auditors.
Outcome of Board Meeting held on 07th February, 2026.
Outcome · 07 Feb 2026, 9:00 pm
Symbiox Investment & Trading Reports Lower Q3 FY26 Net Profit Symbiox Investment & Trading's net profit for the quarter ending 31st Dec'25 fell 92.2% YoY to ₹1.23 lakh from ₹15.85 lakh. Revenue from operations declined 81.1% YoY to ₹8.60 lakh. Sequentially, net profit dropped 79.8% QoQ, while revenue decreased 62.8%. For the nine months ended 31st Dec'25, net profit was ₹14.01 lakh, a 71.5% YoY decline. The Board approved the unaudited financial results on 7th Feb'26. The auditor's limited review report contained no qualifications.
Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 07/02/2026 ,inter alia, to consider and approve Unaudited ....
Intimation · 07 Feb 2026, 5:30 am
Symbiox Investment & Trading Board Meeting to Approve Q3FY26 Results Symbiox Investment & Trading Co. Ltd. announced a board meeting scheduled for 7th Feb'26. The agenda includes the consideration and approval of the unaudited financial results for the quarter ended 31st Dec'25. The board will also review the limited review report for the same period.
Outcome of Board Meeting held on 12th November, 2025.
Outcome · 12 Nov 2025, 9:51 pm
Symbiox Investment & Trading Company Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2025 ,inter alia, to consider and approve Unaudited ....
Intimation · 12 Nov 2025, 5:30 am
The Exchange has sought clarification from Symbiox Investment & Trading Company Ltd on October 27, 2025, with reference to Movement in Price.<BR><BR>The reply is awaited.
Others (Uncategorized) · 27 Oct 2025, 8:56 pm